Takeda- BCH Call for Proposals 2020
Takeda is a global, value-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Boston Children’s Hospital is advancing a strategic collaboration with Takeda focusing on therapeutic areas such as Oncology, Rare Diseases, Neuroscience and Gastroenterology.
The objective of this collaboration is to advance sponsored research at the institutional level based on a mechanism of calls for proposals. Our strategic collaboration is aimed at leveraging both the product development capabilities and funding opportunities of Takeda to bridge the translational and commercial gaps of our early stage technologies.
Pre-proposals are due April 17, 2020. For more information and the pre-proposal form, contact: TIDO.Alliances@childrens.harvard.edu